Not selling CSL. Not buying either.
Plenty happening in the landscape of global healthcare/biotechs. Good to have a holistic view within a resilient sector as a whole. There's been new developments in terms of advancement for treatments for chronic and hereditary conditions. CSL is a spoke in a big wheel. Remove the blinkers. Set yourself free.
just like the pro resources poster who speaks of protecting capital, it should be obvious to all that price makers have a distinct advantage over price takers.
That's how it's been through every market cycle.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$239.10 |
Change
0.000(0.00%) |
Mkt cap ! $115.7B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | $241.14 | $238.23 | $2.391M | 10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 1165 | $253.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $219.65 | 377 | 4 |
View Market Depth
| Last trade - 09.50am 17/06/2025 (20 minute delay) ? |
| CSL (ASX) Chart |